Skip to main content

Table 1 Subjects in the study in patients matched (DM and No-DM separately) for sex, age, BMI, systolic and diastolic blood pressure (surgery vs no-surgery)

From: Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study

Groups

1

3

2

4

Patients (M/W) before matching

74 (16/58)

221 (101/120)**

454 (76/378)

748 (222/526)**

 

DM SURG

DM No-SURG

No-DM SURG

No-DM No-SURG

Patients (M/W)

52 (15/37)

127 (36/91)

333 (78/255)

554 (136/418)

Age (years)

49.9 ± 5.25

51.9 ± 8.61

39.2 ± 10.37

40.2 ± 12.03

BMI (kg/m2)

43.0 ± 3.98

41.9 ± 6.31

41.1 ± 5.36

40.9 ± 7.31

Systolic BP (mmHg)

142.0 ± 12.29

148.0 ± 22.46

134.9 ± 16.48

134.4 ± 16.74

Diastolic BP (mmHg)

85.3 ± 5.95

85.9 ± 11.28

82.3 ± 10.41

82.8 ± 10.42

Heart rate (bpm)

80.9 ± 4.15

77.4 ± 3.64

75.6 ± 4.46

70.4 ± 4.72

Arterial hypertension

15

53

77

132

Creatinine (µmol/l)

74.4 ± 21.95

77.3 ± 25.26

74.6 ± 16.14

76.7 ± 19.84

eGFR (ml/min/1.73 m2)

88.8 ± 20.19

88.0 ± 24.87

92.1 ± 26.13

87.8 ± 18.67

BG (mg/dl)

169.7 ± 60.56

185.3 ± 62.55

92.4 ± 12.69

94.7 ± 12.19

DM drug treatment

6

27

  

HbA1c (%)

7.2 ± 2.19

8.1 ± 1.88

5.7 ± 1.17

5.6 ± 1.25

Total cholesterol (mg/dl)

218.7 ± 43.74

219.4 ± 55.33

210.4 ± 43.26

212.0 ± 98.31

HDL-cholesterol (mg/dl)

50.3 ± 14.71

46.8 ± 13.46

51.1 ± 12.94

50.0 ± 15.10

LDL-cholesterol (mg/dl)

147.6 ± 38.43

144.4 ± 45.23

136.0 ± 37.24

140.2 ± 99.26

Triglycerides (mg/dl)

159.3 ± 80.06

208.8 ± 198.23

127.5 ± 70.62

135.3 ± 68.88

AST (U/l)

30.9 ± 22.28

30.6 ± 22.30

22.8 ± 10.20

24.6 ± 12.44

ALT (U/l)

42.3 ± 31.11

44.6 ± 44.93

31.2 ± 22.70

33.9 ± 22.67

Retinopathy

1

7

  

CHD

0

13*

4

22*

  1. Mean ± SD or absolute frequencies
  2. DM diabetes mellitus, SURG surgery, No-DM nondiabetic, No-SURG non-undergoing surgery, BP blood pressure, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, CHD coronary heart disease
  3. * p < 0.05 surgery versus no surgery; ** p < 0.001 surgery versus no-surgery